Amylyx hires new CMO from Ultragenyx; Eliot Forster is back as a CEO after F-star sale
→ With Amylyx Pharmaceuticals’ ALS drug in full commercial swing, the Massachusetts startup has found a replacement for its chief medical …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
